Quick Answer
L-Tyrosine Mood Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Conclusion Our findings suggest that an 8-week supplementation with Portulaca oleracea can help alleviate depression and stress symptoms in patients with NAFLD.
Key Takeaways
- 01Conclusion Our findings suggest that an 8-week supplementation with Portulaca oleracea can help alleviate depression and stress symptoms in patients with NAFLD. [Milkarizi N (2026)]
- 02Introduction Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition globally. [Milkarizi N (2026)]
- 03Preliminary hypotheses suggest that Portulaca oleracea extract may improve mental health by modulating stress-related hormones. [Milkarizi N (2026)]
- 04Increasing evidence suggests that no single biomarker is likely to capture this complexity, and that integrative multi-omics approaches may provide a more clinically meaningful framework for precision psychiatry. [Kowalczyk Mateusz (2026)]
The current Migaku evidence database contains 2 reusable source documents for L-Tyrosine Mood Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Conclusion Our findings suggest that an 8-week supplementation with Portulaca oleracea can help alleviate depression and stress symptoms in patients with NAFLD. [Milkarizi N (2026); evidence level 2]
- Introduction Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition globally. [Milkarizi N (2026); evidence level 2]
- Preliminary hypotheses suggest that Portulaca oleracea extract may improve mental health by modulating stress-related hormones. [Milkarizi N (2026); evidence level 2]
- Increasing evidence suggests that no single biomarker is likely to capture this complexity, and that integrative multi-omics approaches may provide a more clinically meaningful framework for precision psychiatry. [Kowalczyk Mateusz (2026); evidence level 3]
- The co-occurrence of these conditions increases symptom severity, the risk of relapse, and reduces the likelihood of full remission. [Kowalczyk Mateusz (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Effects of Hydro-Ethanolic Extract of <i>Portulaca oleracea</i> (Purslane) on Depression, Anxiety, and Stress Symptoms in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blind Controlled Trial.
- Amino Acid–Fatty Acid Profile as a Novel Predictive Method in the Assessment of Diagnosis and Treatment Efficacy of Anxiety-Related Disorders and Mood Disorders